MA08.07 Understanding Lung Cancer Patients’ Preferences in Speaking to Their Treatment Team: Insights from a Global Patient Experience Survey

The Global Lung Cancer Coalition (GLCC) is a partnership of 42 patient organisations across 30 nations dedicated to improving outcomes for lung cancer patients. During the COVID-19 pandemic, many lung cancer patients were offered virtual (telephone or video) consultations alongside or instead of face-to-face appointments. Reasons included protecting patients from exposure to the virus, saving travel time, and freeing-up clinical time. As health systems explore the potential of hybrid systems of telemedicine post-COVID-19, the GLCC wanted to understand patients’ preferences for speaking to their treatment team and how they felt about virtual consultations.